Evidence map›Paper›PMID 28947476›Full record

ArticleAntimicrobial agents and chemotherapy2017

Madeline Montenegro, Aaron T Neal, Maritza Posada, Briegel De Las Salas, Tatiana M Lopera-Mesa, Rick M Fairhurst, Alberto Tobon-Castaño

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Artemether-Lumefantrine Efficacy for the Treatment of UncomplicatedThe American journal of tropical medicine and hygiene · 2020
    Article
  4. Artemisinin Resistance Outside of Southeast Asia.The American journal of tropical medicine and hygiene · 2018
    Article
  5. Status of Artemisinin Resistance in Malaria ParasiteBioMed research international · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Madeline MontenegroGrupo Malaria, Universidad de Antioquia, Medellín, Colombia.
Aaron T NealLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Maritza PosadaGrupo Malaria, Universidad de Antioquia, Medellín, Colombia.
Briegel De Las SalasGrupo Malaria, Universidad de Antioquia, Medellín, Colombia.
Tatiana M Lopera-MesaGrupo Malaria, Universidad de Antioquia, Medellín, Colombia.
Rick M FairhurstLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA rfairhurst@niaid.nih.gov alberto.tobon1@udea.edu.co.
Alberto Tobon-CastañoGrupo Malaria, Universidad de Antioquia, Medellín, Colombia rfairhurst@niaid.nih.gov alberto.tobon1@udea.edu.co.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High treatment failure rates for

Indexed as

AdolescentAdultAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsATP-Binding Cassette, Sub-Family C ProteinsColombiaDrug CombinationsDrug ResistanceEthanolaminesFemaleFluorenesHumansMalaria, FalciparumMalePlasmodium falciparumAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsATP-Binding Cassette, Sub-Family C ProteinsDrug CombinationsEthanolaminesFluorenesProtozoan Proteinsantimalarial agentsartemetherartemisininColombiadrug resistanceK13lumefantrinemalariaMdr1

Identifiers

PMID28947476
PMCPMC5700320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.